Skip to Main Content

Paper Details

Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer.
Clin Cancer Res
5
2021
CMS4, CMS4 tumors, CONCLUSIONS Subtype, Colorectal Cancer, EPHA2, Mouse, PDXs, REG, RNA, Regorafenib, consensus, consensus molecular subtype, metastatic colorectal cancer, non-progressor models, patient, tumor, tumors
Author NameAffiliation
Rodrigo DienstmannVall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autonoma de Barcelona
Enzo MedicoUniversity of Torino
Enzo MedicoCandiolo Cancer Institute, FPO-IRCCS
Diether LambrechtsVIB Center for Cancer Biology
Andrea BertottiUniversity of Torino
Andrea BertottiCandiolo Cancer Institute, FPO-IRCCS
Livio TrusolinoUniversity of Torino
Livio TrusolinoCandiolo Cancer Institute, FPO-IRCCS
Annette T ByrneRoyal College of Surgeons in Ireland
Annette T ByrneRoyal College of Surgeons in Ireland
Annette T ByrneUCD Conway Institute, University College Dublin
  • 1 - 11

Datasets

Release 1.2